Market Cap 3.08B
Revenue (ttm) 224.50M
Net Income (ttm) -91.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -40.72%
Debt to Equity Ratio 0.14
Volume 1,231,500
Avg Vol 909,434
Day's Range N/A - N/A
Shares Out 55.33M
Stochastic %K 28%
Beta 1.07
Analysts Strong Sell
Price Target $75.78

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 232 7200
Address:
150 Baytech Drive, San Jose, United States
Muddymac
Muddymac Jul. 26 at 4:46 PM
$PRCT From last year to this year, capital sales have dropped from almost half of revenue to 27%. This is going to become a utilization growth game very soon. Very different strategy and execution to grow procedural growth at the same accounts than opening new accounts with an expensive capital purchase. Let’s see how they do with a new CEO starting in Sept.
1 · Reply
SOFIdude
SOFIdude Jul. 25 at 10:51 AM
$PRCT https://ir.procept-biorobotics.com/news-releases/news-release-details/ambulatory-surgery-center-completes-water-iv-trial-procedures
0 · Reply
SOFIdude
SOFIdude Jul. 25 at 10:43 AM
$PRCT https://www.tipranks.com/news/the-fly/procept-biorobotics-sees-q2-revenue-79-2m-consensus-75-94m-thefly#google_vignette
0 · Reply
Markpokoron
Markpokoron Jul. 19 at 4:30 AM
$PRCT broke a major trendline. Eyes on how it reacts here.
0 · Reply
JasonCO
JasonCO Jul. 18 at 7:53 PM
$PRCT besutiful pump and dump today mm no one fooled
1 · Reply
StockHunter75
StockHunter75 Jul. 15 at 2:28 PM
$PRCT Buying some
0 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 1:12 PM
Morgan Stanley updates rating for PROCEPT BioRobotics ( $PRCT ) to Overweight, target set at 71 → 68.
0 · Reply
Quantumup
Quantumup Jul. 15 at 1:07 PM
BofA reit'd $PRCT Buy-$84 after Center of Medicare and Medicaid Services (CMS) released its proposed physician fee schedule (PFS) for 2026 which includes what a doctor will get paid to perform PRCT's Aquablation under its new Category I CPT code. $BSX $ISRG $SYK $MDT GEHC BofA said in its note:
0 · Reply
Lambster2
Lambster2 Jul. 15 at 11:39 AM
$PRCT Procept BioRobotics Corp (NASDAQ: PRCT) Buy (1) ESG Score: 67/100 Price Target: $85.00 CMS Proposed PFS Aquablation Reimbursement Lower vs Prior Assumption THE TD COWEN INSIGHT CMCMS proposed a 2026 Medicare physician payment of ~$542 for Aquablation under a new Category I CPT code - below our ~$600 estimate that we published last night. The impact of lower physician reimbursement level on Aquablation adoption and utilization will continue to be debated and the overhang may not be fully removed in the near term.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 15 at 3:30 AM
$DASH $JD $NFLX $PRCT $SOUN Hello Everyone, I have now posted information regarding analyst reports/notes for the companies mentioned in the re-shared post below. I hope this information is useful to everyone. Best, DC77
0 · Reply
Latest News on PRCT
Procept BioRobotics: Continued Growth Runway Ahead

Nov 26, 2024, 5:10 AM EST - 8 months ago

Procept BioRobotics: Continued Growth Runway Ahead


Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 27, 2024, 8:30 AM EDT - 11 months ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval


Muddymac
Muddymac Jul. 26 at 4:46 PM
$PRCT From last year to this year, capital sales have dropped from almost half of revenue to 27%. This is going to become a utilization growth game very soon. Very different strategy and execution to grow procedural growth at the same accounts than opening new accounts with an expensive capital purchase. Let’s see how they do with a new CEO starting in Sept.
1 · Reply
SOFIdude
SOFIdude Jul. 25 at 10:51 AM
$PRCT https://ir.procept-biorobotics.com/news-releases/news-release-details/ambulatory-surgery-center-completes-water-iv-trial-procedures
0 · Reply
SOFIdude
SOFIdude Jul. 25 at 10:43 AM
$PRCT https://www.tipranks.com/news/the-fly/procept-biorobotics-sees-q2-revenue-79-2m-consensus-75-94m-thefly#google_vignette
0 · Reply
Markpokoron
Markpokoron Jul. 19 at 4:30 AM
$PRCT broke a major trendline. Eyes on how it reacts here.
0 · Reply
JasonCO
JasonCO Jul. 18 at 7:53 PM
$PRCT besutiful pump and dump today mm no one fooled
1 · Reply
StockHunter75
StockHunter75 Jul. 15 at 2:28 PM
$PRCT Buying some
0 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 1:12 PM
Morgan Stanley updates rating for PROCEPT BioRobotics ( $PRCT ) to Overweight, target set at 71 → 68.
0 · Reply
Quantumup
Quantumup Jul. 15 at 1:07 PM
BofA reit'd $PRCT Buy-$84 after Center of Medicare and Medicaid Services (CMS) released its proposed physician fee schedule (PFS) for 2026 which includes what a doctor will get paid to perform PRCT's Aquablation under its new Category I CPT code. $BSX $ISRG $SYK $MDT GEHC BofA said in its note:
0 · Reply
Lambster2
Lambster2 Jul. 15 at 11:39 AM
$PRCT Procept BioRobotics Corp (NASDAQ: PRCT) Buy (1) ESG Score: 67/100 Price Target: $85.00 CMS Proposed PFS Aquablation Reimbursement Lower vs Prior Assumption THE TD COWEN INSIGHT CMCMS proposed a 2026 Medicare physician payment of ~$542 for Aquablation under a new Category I CPT code - below our ~$600 estimate that we published last night. The impact of lower physician reimbursement level on Aquablation adoption and utilization will continue to be debated and the overhang may not be fully removed in the near term.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 15 at 3:30 AM
$DASH $JD $NFLX $PRCT $SOUN Hello Everyone, I have now posted information regarding analyst reports/notes for the companies mentioned in the re-shared post below. I hope this information is useful to everyone. Best, DC77
0 · Reply
DonCorleone77
DonCorleone77 Jul. 15 at 3:26 AM
$PRCT Information regarding Wells Fargo analyst report on PRCT issued yesterday: https://x.com/CorleoneDon77/status/1944959991955234865
0 · Reply
DonCorleone77
DonCorleone77 Jul. 14 at 7:21 PM
$DASH $JD $NFLX $PRCT $SOUN Hey Everyone, In addition to the information relating to company analyst reports/notes that I posted today, I will also be posting information regarding analyst reports/notes this evening for the following companies: 1) AZN 2) CLF 3) COIN 4) CORZ 5) CRWD 6) DASH 7) JD 8) NFLX 9) PRCT 10) SOUN Feel free to check back this evening if any of these companies are of interest to you. I hope this information is useful to many members. Best, DC77
1 · Reply
GoldenTradesCapital
GoldenTradesCapital Jul. 11 at 12:31 PM
STOCK RECOMMENDATION: $PRCT – ROBOTIC SURGERY INNOVATOR 🔬 Procept Biorobotics is disrupting urology with precision tech. Small cap, high growth. Follow us for next-gen medtech stocks 🔱
0 · Reply
Src947
Src947 Jul. 11 at 9:32 AM
$PRCT July calls acting funny….$65 calls bid $1.
0 · Reply
HodlMaBeer
HodlMaBeer Jul. 9 at 5:12 PM
$PRCT wake up!!
0 · Reply
Quantumup
Quantumup Jul. 9 at 1:08 PM
Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT" $BSX $ISRG $SYK $MDT #BPH #PCa Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand. Stephens added: ● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery. ● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.
0 · Reply
JarvisFlow
JarvisFlow Jul. 7 at 1:52 PM
Oppenheimer has updated their rating for PROCEPT BioRobotics ( $PRCT ) to Perform.
0 · Reply
DoctorTy
DoctorTy Jul. 6 at 8:54 PM
$PRCT this will be 200$ stock in 2-3 years .AI and robotic surgery will be huge. May be bigger than anything
0 · Reply
Spd2base
Spd2base Jun. 25 at 9:52 PM
$PRCT why does overnight price not show on Robinhood?
0 · Reply
Quantumup
Quantumup Jun. 18 at 2:23 PM
Truist reiterated $PRCT Buy-$70. $BSX $ISRG $MDT $TNDM SYK Truist said in its note: "We believe gdce continues to leave room for upside given mgmt. commentary (a) it's trying to be conservative (still early in yr) (b) healthy March utilization momentum is carrying over into April/May, and (c) CFO Waters continues to emphasize a high degree of confidence on capital pipeline leads as well as increasingly predictable capital conversions (helped by more IDN placements). Mgmt. sees handpiece gdce continuing to set-up for beat & raises, and the decision to exercise "restraint"---holding back a bigger initial raise following the 1Q handpiece upside---was made in this vein (to guide conservatively early in the year)."
0 · Reply
QES
QES Jun. 12 at 12:42 AM
$PROF How PROF compares to $PRCT PROF is the clear winner
3 · Reply
med_bull
med_bull Jun. 9 at 9:07 PM
$PRCT bought another 1000 shares today
0 · Reply